Navigation Links
A Smoking Gene: deCODE Shows How a Single Variant in the Sequence of the Genome Confers Nicotine Dependence and Risk of Lung Cancer and Other Disease
Date:4/2/2008

lung cancer and peripheral arterial disease,' is published today in the online edition of Nature, at http://www.nature.com.

"These findings provide an example of the power of human genetics for shedding light on the most complex health challenges. Not only have we made a convincing link between a single SNP and a behavioral disorder -- greater smoking quantity and addiction to nicotine -- but also demonstrated how this risk factor translates into risk of lung cancer and PAD. This is an important advance that we will use in our diagnostics programs to develop means to enable individuals and their doctors to better understand and reduce the risk of smoking to their health. As of today we have also integrated this variant into our deCODEme(TM) personal genome analysis service," said Kari Stefansson, CEO of deCODE.

The deCODE team began this study with a smoking history questionnaire distributed to some 50,000 Icelanders, in which respondents were asked to say whether they had ever smoked, were still smokers, and, if so, how many cigarettes they smoked per day. More than 300,000 SNPs were then analysed in a subset of more than 10,000 smokers participating in deCODE's research, and the "T" version SNP rs1051730 was shown to be more common in heavier smokers than in smokers overall and in the general population. It was also correlated with likelihood of clinical diagnosis of nicotine dependence. Interestingly, the variant is less common among smokers who smoked less than 10 cigarettes per day than it is among non-smokers, supporting the notion that the variant does not influence smoking initiation, but rather confers risk of nicotine dependence among those who start. The variant was then analyzed in a total of 32,000 patients and controls from Iceland, New Zealand, Austria, Sweden, Italy, the Netherlands and Spain for lung cancer and PAD, two common diseases strongly associated with smoking.

deCODE gra
'/>"/>

SOURCE deCODE
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Misperceptions About Smoking Cessation Aids May Hinder Smokers From Using Effective Treatment for Quitting
2. Evotec Starts Phase II in Smoking Cessation with EVT 302
3. Transgene: Cash Position of EUR 119 Million as of September 30, 2007
4. deCODE genetics to Webcast Presentation at 15th Annual Future Leaders in the Biotech Industry Conference
5. deCODE genetics to Webcast Presentation at Lehman Brothers Eleventh Annual Global Healthcare Conference
6. deCODE Genetics Announces Full-year 2007 Financial Results
7. deCODE genetics Announces Webcast of Conference Call to Discuss Full-year 2007 Financial Results
8. deCODE genetics to Webcast Presentation at BIO CEO and Investor Conference
9. deCODE Discovers Gene Variants that May Help to Distribute the Work of Evolution between Men and Women
10. deCODE genetics to Webcast Presentation at JPMorgan Annual Healthcare Conference
11. deCODE Launches deCODEme(TM)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... 2015   California Cryobank Stem Cell Services LLC ... Cryogenics, an east coast cord blood and reproductive tissue ... tristate area. LifeLine clients will maintain full access ... be honored. Since 1991, LifeLine has provided ... sperm, eggs, embryos, and cord blood stem cells. LifeLine Cryogenics ...
(Date:8/3/2015)... -- MiMedx Group, Inc. (NASDAQ: MDXG ), the leading ... processes to develop and market advanced products and therapies ... Ophthalmic and Dental sectors of healthcare, announced today that ... Canaccord|Genuity Growth Conference in Boston, Massachusetts ... William C. Taylor , President and COO, and ...
(Date:8/3/2015)... 2015 E-QURE Corp. (OTCQB: EQUR), ... Bio-electrical Signal Therapy device ("BST Device"), a new and ... heal chronic wounds, today announced that the Company has ... distributor specializing in medical devices, for the marketing and ... a 70 years old, sales, marketing and distribution company ...
(Date:7/31/2015)... , July 31, 2015 In today,s ... that help them drive positive health outcomes, improve ... source of patient care in their communities. At ... tradeshow and conference, AmerisourceBergen announced a new set ... Services Administration Organization and help independent pharmacies endure ...
Breaking Biology Technology:FamilyCord Announces Acquisition of LifeLine Cryogenics 2MiMedx To Present At 35th Annual Canaccord|Genuity Growth Conference 2E-QURE Corp Signs Second Distribution Agreement in Israel 2E-QURE Corp Signs Second Distribution Agreement in Israel 3AmerisourceBergen Unveils Suite of Enhanced Capabilities for Independent Pharmacies at ThoughtSpot 2015 2AmerisourceBergen Unveils Suite of Enhanced Capabilities for Independent Pharmacies at ThoughtSpot 2015 3
... a year and a half, cells from pigs are to be ... ... The Lions Clubs of Multiple,District 5M (MD5M) recently declared its ... expedite the,affordable and widespread availability of pig donors of islet tissue ...
... Less Potential for ... SAN DIEGO, July 29 Orexigen(R) Therapeutics,Inc. (Nasdaq: ... Patent and,Trademark Office (USPTO) issued a Notice of Allowance ... a pharmaceutical,composition of zonisamide in combination with a series ...
... Mass., July 29 Inverness Medical,Innovations, Inc. (Amex: ... today announced its financial results for the quarter,ended June ... the Company recorded net revenue of,$401.1 million compared to ... 2007. The revenue increase was primarily due to increased,product ...
Cached Biology Technology:Spring Point Project Gains Support of Lions Clubs 2Spring Point Project Gains Support of Lions Clubs 3OREXIGEN(R) Therapeutics Receives Notice of Allowance for U.S. Patent Covering the Composition of Matter in OREX-003 2OREXIGEN(R) Therapeutics Receives Notice of Allowance for U.S. Patent Covering the Composition of Matter in OREX-003 3OREXIGEN(R) Therapeutics Receives Notice of Allowance for U.S. Patent Covering the Composition of Matter in OREX-003 4Inverness Medical Innovations Announces Second Quarter 2008 Results 2Inverness Medical Innovations Announces Second Quarter 2008 Results 3Inverness Medical Innovations Announces Second Quarter 2008 Results 4Inverness Medical Innovations Announces Second Quarter 2008 Results 5Inverness Medical Innovations Announces Second Quarter 2008 Results 6Inverness Medical Innovations Announces Second Quarter 2008 Results 7Inverness Medical Innovations Announces Second Quarter 2008 Results 8Inverness Medical Innovations Announces Second Quarter 2008 Results 9Inverness Medical Innovations Announces Second Quarter 2008 Results 10Inverness Medical Innovations Announces Second Quarter 2008 Results 11Inverness Medical Innovations Announces Second Quarter 2008 Results 12Inverness Medical Innovations Announces Second Quarter 2008 Results 13Inverness Medical Innovations Announces Second Quarter 2008 Results 14Inverness Medical Innovations Announces Second Quarter 2008 Results 15Inverness Medical Innovations Announces Second Quarter 2008 Results 16
(Date:7/9/2015)... SAN JOSE, Calif. , July 9, 2015 /PRNewswire/ ... human interface solutions, announced today that it will report ... 2015 on Thursday, July 30, 2015 after the close ... call for analysts and investors at 2:00 p.m. PT ... information.    To participate on the live ...
(Date:7/8/2015)... Summary Pancreatic cancer is the 12th ... with a mortality rate of 10.9 deaths per 100,000 ... patients has highlighted a significant need for new and ... by the current market. A highly active pancreatic ... molecule types and mechanisms of action, which provides a ...
(Date:7/7/2015)... -- Research and Markets ( ... "Capacitive Fingerprint Sensors Patent Landscape" report ... fingerprint sensing technology is the most reliable and ... developed. This patent landscape focuses on fingerprint sensors ... of capacitive fingerprint sensors is closely linked to ...
Breaking Biology News(10 mins):Synaptics to Report Fourth Quarter, Fiscal Year 2015 Results on July 30 2Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation 2Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation 3Worldwide Capacitive Fingerprint Sensors Patent Landscape Market Report 2015-2020 - Main IP Holders include Seiko Epson, AuthenTec, Sony and STMicroelectronics 2
... Calif.) Sensors made from custom DNA molecules could be ... stem cells, according to an international team of researchers led ... Rome Tor Vergata. The new nanosensors can quickly detect ... as the master control switches of life. The research is ...
... series of research flights from the Arctic to the ... gases and particles in the atmosphere, scientists announced today. ... enabling researchers to generate the first detailed mapping of ... Earth,s climate. The series of flights, which come ...
... new way to detect the activity of proteins that bind ... genes in ways that make cells do everything from growing ... Journal of the American Chemical Society . Kevin ... percent of the 25,000-30,000 genes in the human body contain ...
Cached Biology News:Nanosensors made from DNA may light path to new cancer tests and drugs 2Nanosensors made from DNA may light path to new cancer tests and drugs 3First global portrait of greenhouse gases emerges from pole-to-pole flights 2First global portrait of greenhouse gases emerges from pole-to-pole flights 3First global portrait of greenhouse gases emerges from pole-to-pole flights 4
HSV 1 IgM...
... choice of Printing Surface (3 glass slides coated with ... 1 silicon wafer coated with 1000 Angstroms of Gold ... PDMS Stamps (3 PDMS micropatterned stamps with series of ... 10 mm or 200 um x 10 mm lines, ...
XBP-1 (F-4)...
ECE-1 (H-60)...
Biology Products: